Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 Index Fund (NY:IWM)

274.12 +3.14 (+1.16%)
Delayed Quote Updated: 1:54 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 Index Fund

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
News headline image
Stocks Slip As Gold Rebounds To $3,330, Bitcoin Holds $102,000: What's Driving Markets Friday? ↗
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by... 
Via Benzinga
News headline image
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish ↗
CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three... 
Via Stocktwits
Topics Lawsuit
News headline image
Verastem’s Combination Therapy For Ovarian Cancer Gets FDA Approval: Retail’s Pleased ↗
The combination of Avutometinib capsules and Defactinib tablets, under the brand name Avmapki Fakzynja Co-pack, can now be used to treat patients with KRAS-mutated recurrent low-grade serous ovarian... 
Via Stocktwits
News headline image
Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says ↗
U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement with the United Kingdom, igniting optimism about further global deals — especially with China — and... 
Via Benzinga
Topics Government
News headline image
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated ↗
The company raised its full-year revenue guidance to between $975 million and $1.025 billion, up from its previous guidance of between $300 million and $350 million. 
Via Stocktwits
News headline image
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday? ↗
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET. 
Via Benzinga
Topics Economy
News headline image
EVgo Reports Upbeat Q1 Earnings, CEO Expects Minimal Impact From Trump Tariffs: Retail’s Thrilled ↗
The company also affirmed its full-year revenue guidance of $340 million to $380 million. 
Via Stocktwits
Topics Government World Trade
News headline image
Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday? ↗
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting. 
Via Benzinga
Topics Economy
News headline image
CorMedix Q1 Earnings Trump Estimates: Retail’s Overjoyed ↗
The company reported net revenue of $39.1 million for the first quarter from the sales of DefenCath, above an analyst estimate of $36, as per Finchat data. 
Via Stocktwits
Topics Earnings Government
News headline image
Nasdaq, S&P 500 Futures Slip As Fed Jitters, Tariff Risks Weigh On Market Mood: Economist Says Investors Pricing In ‘Average Risk’ ↗
According to Morgan Stanley's Matt Wilson, the 5,750-5,800 area — the convergence of the 200-day and 100-day moving averages — is the most critical technical test for the S&P 500 Index. 
Via Stocktwits
Topics Economy Stocks
News headline image
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
News headline image
BioCryst Pharma Stock Soars 10% Pre-Market On Upbeat Q1 Earnings, Improved Full Year Guidance: Retail’s Pleased ↗
BioCryst now expects global net Orladeyo revenue to be between $580 million and $600 million for the full year, up from its previous guidance of between $535 million and $550 million. 
Via Stocktwits
News headline image
S&P 500, Dow Jones Futures Slip After 9-Day Rally As Fed Decision Looms: Why One Strategist Says Fed Must Act Now ↗
Positive tech earnings have set the tempo for the recent uptrend, and removal of the tariff overhang would further solidify the rally. 
Via Stocktwits
Topics Economy Government Stocks
News headline image
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions ↗
U.S. stocks rose on hopes of China's willingness to negotiate a trade deal regarding fentanyl production. Tech stocks led the rally. 
Via Benzinga
News headline image
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday? ↗
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024. 
Via Benzinga
News headline image
S&P 500, Dow Futures Surge As China Trade Deal Hopes Offset Big Tech Disappointment — Analyst Tells Why Market May Have Bottomed ↗
The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March. 
Via Stocktwits
Topics ETFs Economy Stocks
News headline image
Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday? ↗
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully... 
Via Benzinga
Topics Government Stocks World Trade
News headline image
Nasdaq, Dow Jones Futures Rise On Meta, Microsoft Results: Apple Earnings Loom, Analyst Doubts New Bull Run For Stock Markets ↗
Notwithstanding the recent seven-session run, the S&P 500 Index ended April — a historically strong month — with a loss of 0.8%. 
Via Stocktwits
Topics Economy Stocks World Trade
News headline image
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis ↗
According to the terms of the deal, Novartis, through a subsidiary, will initiate a tender offer to acquire all of Regulus' outstanding shares for an initial price of $7.00 per share or $800 million. 
Via Stocktwits
News headline image
US Stock Futures Slip Ahead Of Meta, Microsoft Earnings, Inflation Print: Strategist Sees Choppy Waters Ahead ↗
Notwithstanding the resurgence seen since last week, the market is likely to end April with a monthly loss, with the S&P 500 down 0.90% with a session to go. 
Via Stocktwits
Topics Economy Government Stocks
News headline image
Financial Markets Report For Monday, April 28 ↗
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Monday, April 28. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
News headline image
Wall Street Falls On Weak Economic Data As Oil Slumps To $58: What's Driving Markets Wednesday ↗
Wall Street traded lower on the final session of the month, heading for its third consecutive monthly loss as economic data began reflecting the impact of Trump tariffs. 
Via Benzinga
Topics Government
News headline image
Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday? ↗
Wall Street modestly up as investors await economic data and corporate earnings. Bond market continues rally, gold and oil prices fall.Wall Street rises modestly, bond market continues rally, gold and... 
Via Benzinga
Topics Bonds
News headline image
US Stock Futures Climb As Traders Eye Consumer Confidence, Jobs Data: Strategist Lists 4 Factors For Sustained S&P 500 Breakout ↗
On Monday, the major averages settled on a mixed note as traders adopted a "wait-and-watch" approach following four straight sessions of gains. 
Via Stocktwits
Topics ETFs Economy Stocks
News headline image
We're In A Holding Pattern - And That’s OK ↗
As the market grinds - and, today, pauses - it’s all to easy to step out ahead and tip your hand early. 
Via Talk Markets
Topics Commodities Stocks / Equities
News headline image
US Stock Futures Slip After Stellar Weekly Surge: Analyst Expects 'Confidence Booster' From More Big Tech Earnings ↗
Wedbush analyst Daniel Ives said this was a major week ahead for the markets and that he braced for generally strong results from the big techs due to very favorable demand trends. 
Via Stocktwits
Topics Economy Government Stocks
News headline image
Futures Positions Of Non-Commercials: Latest CoT Report ↗
A dramatic confrontation between the White House and the Federal Reserve has been put off – for now. Come Tuesday, Trump said he has “no intention” of firing Powell before his term ends. 
Via Talk Markets
Topics Bonds Commodities Currencies/Forex
News headline image
The Major Sector ETFs Got Their Story ↗
XRT has more work to do. At best, the consumer sector is trying to bottom. At worst, this is a rally into resistance. 
Via Talk Markets
Topics ETFs
News headline image
Wall Street Bets On Bulls, Not Tariffs, As Rare 'Breadth Thrust' Lifts Stocks ↗
A rare technical signal is drawing attention on Wall Street, pointing to possible gains for U.S. stocks even as tariff concerns from ... 
Via Benzinga
Topics World Trade
News headline image
Technical Market Report For April 26, 2025 ↗
New lows have declined to the point of insignificance. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.